Whitehawk Therapeutics (WHWK) Depreciation & Amortization (CF) (2016 - 2026)
Whitehawk Therapeutics (WHWK) reported Depreciation & Amortization (CF) of $1000.0 for Q1 2026, down 98.25% year-over-year from $57000.0 in Q1 2025, and down 82.14% quarter-over-quarter from $5600.0 in Q3 2025.
Whitehawk Therapeutics (WHWK) Depreciation & Amortization (CF) (2016 - 2026) Analysis & Trends
Whitehawk Therapeutics (WHWK) has 11 years of Depreciation & Amortization (CF) data on file, last reported at $1000.0 in Q1 2026.
- Depreciation & Amortization (CF) for Q1 2026 came in at $1000.0, down 98.25% year-over-year; the trailing twelve-month figure through Mar 2026 was $21900.0 (down 91.35% YoY), and the FY2025 annual result was $79000.0, down 59.07% from the prior year.
- Depreciation & Amortization (CF) declined to $1000.0 in Q1 2026 per WHWK's latest filing, from $5600.0 in the prior quarter.
- Over five years, Depreciation & Amortization (CF) peaked at $100000.0 in Q4 2024 and troughed at $1000.0 in Q1 2026.
- A 5-year average of $40825.0 and a median of $44000.0 in 2023 frame the typical range for Depreciation & Amortization (CF).
- The sharpest annual moves came in 2022 and 2026: Depreciation & Amortization (CF) surged 3600.0% in 2022, then plunged 98.25% in 2026.
- A 5-year view of Depreciation & Amortization (CF) shows it stood at $46000.0 in 2022, then declined by 4.35% to $44000.0 in 2023, then jumped by 127.27% to $100000.0 in 2024, then plunged by 94.4% to $5600.0 in 2025, then plunged by 82.14% to $1000.0 in 2026.
- Business Quant data shows WHWK's Depreciation & Amortization (CF) at $1000.0 in Q1 2026, $5600.0 in Q3 2025, and $15300.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1,395.22 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1,330.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 55.90 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 429,663.65 |
| 10 | Whitehawk Therapeutics | 310.18 Mn | 187.14 Mn | - | 1,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,000.00 |
| Mar 31, 2026 | 1,000.00 |
| Sep 30, 2025 | 5,600.00 |
| Sep 30, 2025 | 5,600.00 |
| Jun 30, 2025 | 15,300.00 |
| Jun 30, 2025 | 15,300.00 |
| Mar 31, 2025 | 57,000.00 |
| Mar 31, 2025 | 57,000.00 |
| Dec 31, 2024 | 100,000.00 |
| Dec 31, 2024 | 100,000.00 |
| Sep 30, 2024 | 46,700.00 |
| Sep 30, 2024 | 46,700.00 |
| Jun 30, 2024 | 49,600.00 |
| Jun 30, 2024 | 49,600.00 |
| Mar 31, 2024 | 50,000.00 |
| Mar 31, 2024 | 50,000.00 |
| Dec 31, 2023 | 44,000.00 |
| Dec 31, 2023 | 44,000.00 |
| Sep 30, 2023 | 44,000.00 |
| Sep 30, 2023 | 44,000.00 |